Volition is an innovative company specializing in healthcare solutions, particularly in the development of easy-to-use blood tests designed for the early detection of cancers and other diseases. With a strong focus on scientific research, Volition leverages its proprietary Nucleosomics™ technology that analyzes nucleosome profiles to identify various health conditions. Headquartered in Belgium, the company collaborates with global partners to advance diagnostic accuracy and accessibility. Volition is committed to revolutionizing disease diagnosis and management, aiming for more efficient and cost-effective healthcare practices. Their approach promises to enhance patient care through early and reliable disease detection.